Definition: Osteonecrosis of the jaw (ONJ) is death of bone tissue in the jaw. It is a listed warning on bisphosphonate labels such as Fosamax and Reclast and on the Prolia (denosumab) label. Reported cases are usually linked to a tooth extraction or a local infection that heals slowly.
The Fosamax label (section 5.4) says jaw bone death has been reported, usually with tooth extraction or local infection with slow healing. It lists these risk factors:
The Fosamax label adds that the risk may grow with longer use. The Prolia label also lists jaw bone death, usually linked to tooth extraction or infection with slow healing.
Because dental work is the main trigger named, the date of your last dose and how long you have been on the drug are useful to a dentist. A clear record of every weekly tablet, yearly infusion or six-month shot answers both questions. Labels set the length of use with the prescriber, not the dentist, so changes to the plan go through them.
ONJ is different from the unusual thigh fractures on the same labels, though both are tied to long-term use of bone drugs. Both are listed as warnings, not as common side effects in the trial tables.
Read more on Dose Track: Fosamax side effects · Prolia side effects · Reclast side effects